Hims & Hers review
Mass-market, app-first weight program with nationwide reach and consumer-grade polish.
Hims & Hers — FDA warning letter, September 2025. Addressed to Hims & Hers Health, Inc. dba Hims, and public in FDA’s warning-letter database.
- Semaglutide
- $199/mo
- Tirzepatide
- Not disclosed
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
Hims & Hers scored on our six published factors. See the methodology.
What we like
- Nationwide
- Slick app experience
- Strong brand trust
The caveats
- Tirzepatide pricing not consistently disclosed
- Compounded supply has drawn regulatory scrutiny industry-wide
- FDA issued a warning letter to Hims & Hers Health, Inc. dba Hims in September 2025; it is public in FDA's warning-letter database
The verdict
Best for: People who want a familiar, app-driven consumer brand. Mass-market, app-first weight program with nationwide reach and consumer-grade polish.
Ranked #27 of 539 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. In the ranking it sits between NiceRx at #26, 85/100 above and No BS RX at #28, 85/100 below, with the Renlo Health ruling the next one down.
A grade B is a ranking, not an instruction to stop looking: the closest rivals to Hims & Hers are ruled on the identical rubric, so the comparison is like for like.This ruling sits inside a bigger one: where semaglutide is cheapest puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Hims & Hers goes to CoreAge Rx, 94/100 to 85/100.
Compare with other providers
The closest rulings to Hims & Hers by Verdict Score — the realistic shortlist if you are weighing this one up.
- #14Effecty— A LegitScript-verified nationwide operator that pairs fair compounded pricing with real brand-name access.87/100
- #15Curex— One flat price for either molecule, an oral route for the needle-averse, and a LegitScript-verified nationwide footprint.87/100
- #16Ro— A heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.87/100
- #17yourEra— One of the rare compounded programs that puts its price on the page — $199 semaglutide and $299 tirzepatide, both molecules, nationwide — wrapped in a broader longevity menu, but the verdict holds it at mid-pack because everything is compounded, injectable-only, and the 50-state and results claims are self-reported with a thin independent track record.84/100
- #18Strut Health— The only program here selling the same molecule as a lozenge or an injection at the same price — the needle is genuinely optional, though the company carries an FDA warning letter from February 2026.84/100
- #19MadeMed— Publishes its price at every single dose, so the cost of the dose you titrate to is knowable on day one rather than a surprise at month four.84/100
Pricing, states and verification reflect Hims & Hers's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Hims & Hers's site. Not medical advice; see our disclosure.